Cinkate Pharmaceutical Intermediates Co., Ltd.

Calculating rank

USPTO Granted Patents = 2

EPO Patents = 2

Forward Citations = 0

Loading Chart...

9 inventors (with patents filed for the assignee):

Fei Xiao (2 out of 3 patents)

Peng Zhang (1 out of 112 patents)

Bo Qiu (1 out of 1 patent)

4. Na Liu (1 out of 9 patents)

5. Lixia Bao (1 out of 1 patent)

6. Zhepeng Wei (1 out of 1 patent)

7. Yufeng Zhou (1 out of 1 patent)

8. Bin Rong (1 out of 2 patents)

9. Lihui Zhao (1 out of 5 patents)

2 patents: Sort by Forward Citations

1. 11591333 - Substituted pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors (2023-02-28),

2. 11407783 - Triptolide derivative and preparation method therefor and use thereof (2022-08-09),

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

2 Patents

#901 in Shanghai

#11,649 in China

Shanghai, China

Cinkate Pharmaceutical Intermediates Co., Ltd.

Forward Citations = 0

9 inventors:

Fei Xiao (2 out of 3 patents)

Peng Zhang (1 out of 112 patents)

Bo Qiu (1 out of 1 patent)

4. Na Liu (1 out of 9 patents)

5. Lixia Bao (1 out of 1 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Cinkate Pharmaceutical Intermediates Co., Ltd.. Retrieved from https://idiyas.com/company/cinkate-pharmaceutical-intermediates-company

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]